Considering the diversity of cells, the complexity of signaling, and the contradictory effect of P2X7 receptor in the TME, the application of P2X7 receptor-blocking therapy to restrain tumor growth and boost the anti-tumor immunity will only be feasible after our complete understanding of its role in the host-tumor interaction. Here, P2RX7 is linked to neoplasm.